CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4810-4818

  Gleissner, Christian A ^a,b   Shaked, Iftach ^a   Little, Kristina M ^a   Ley, Klaus ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; ALPHA CHEMOKINE; ANTIGEN; CHOLESTEROL; COLONY STIMULATING FACTOR 1; CXC CHEMOKINE LIGAND 4; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; LIPID; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PROTEIN; SCAVENGER RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG; ZYMOSAN; BIOLOGICAL MARKER; THROMBOCYTE FACTOR 4;

ANTIGEN PRESENTATION; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LIPID METABOLISM; MACROPHAGE; MICROCHIP ANALYSIS; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; BLOOD; CELL LINEAGE; CELL POLARITY; COMPARATIVE STUDY; CYTOLOGY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL POLARITY; CELLS, CULTURED; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; PLATELET FACTOR 4;

EID: 77954507872     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901368     Document Type: Article

References (35)

1. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
2. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol. 103: 191-200.
3. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis: I. Transition of blood-bornemonocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181-190.
4. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
5. Galkina, E. V., and K. Ley. 2009. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27: 165-197.
6. Gordon, S. 2007. Macrophage heterogeneity and tissue lipids. J. Clin. Invest. 117: 89-93.
7. Varin, A., and S. Gordon. 2009. Alternative activation of macrophages: Immune function and cellular biology. Immunobiology [Epub ahead of print].
8. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
9. Bouhlel, M. A., B. Derudas, E. Rigamonti, R. Dièvart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N. Marx, et al. 2007. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 6: 137-143.
10. Waldo, S. W., Y. Li, C. Buono, B. Zhao, E. M. Billings, J. Chang, and H. S. Kruth. 2008. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172: 1112-1126.
11. Boyle, J. J., H. A. Harrington, E. Piper, K. Elderfield, J. Stark, R. C. Landis, and D. O. Haskard. 2009. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 174: 1097-1108.
12. Metcalf, D. 1986. The molecular biology and functions of the granulocytemacrophage colony-stimulating factors. Blood 67: 257-267.
13. Scheuerer, B., M. Ernst, I. Dürrbaum-Landmann, J. Fleischer, E. Grage-Griebenow, E. Brandt, H. D. Flad, and F. Petersen. 2000. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95: 1158-1166.
14. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177: 7303-7311.
15. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L. D. Shultz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444. (Pubitemid 120014957)
16. de Villiers, W. J., J. D. Smith, M. Miyata, H. M. Dansky, E. Darley, and S. Gordon. 1998. Macrophage phenotype in mice deficient in both macrophagecolony-stimulating factor (op) and apolipoprotein E. Arterioscler. Thromb. Vasc. Biol. 18: 631-640.
17. Gewirtz, A. M., B. Calabretta, B. Rucinski, S. Niewiarowski, and W. Y. Xu. 1989. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J. Clin. Invest. 83: 1477-1486.
18. Gleissner, C. A., and K. Ley. 2007. CXCL4 in atherosclerosis: possible roles in monocyte arrest and macrophage foam cell formation. Thromb. Haemost. 98: 917-918.
19. Kasper, B., E. Brandt, S. Brandau, and F. Petersen. 2007. Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J. Immunol. 179: 2584-2591.
20. Gleissner, C. A., P. von Hundelshausen, and K. Ley. 2008. Platelet chemokines in vascular disease. Arterioscler. Thromb. Vasc. Biol. 28: 1920-1927.
21. Pitsilos, S., J. Hunt, E. R. Mohler, A. M. Prabhakar, M. Poncz, J. Dawicki, T. Z. Khalapyan, M. L. Wolfe, R. Fairman, M. Mitchell, et al. 2003. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb. Haemost. 90: 1112-1120.
22. -/- mice. Thromb. Haemost. 98: 1108-1113.
23. Gleissner, C. A., I. Shaked, C. Erbel, D. Böckler, H. A. Katus, and K. Ley. 2010. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ. Res. 106: 203-211.
24. Cho, H. J., P. Shashkin, C. A. Gleissner, D. Dunson, N. Jain, J. K. Lee, Y. Miller, and K. Ley. 2007. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol. Genomics 29: 149-160.
25. Jain, N., J. Thatte, T. Braciale, K. Ley, M. O'Connell, and J. K. Lee. 2003. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19: 1945-1951.
26. Jain, N., H. Cho, M. O'Connell, and J. K. Lee. 2005. Rank-invariant resampling based estimation of false discovery rate for analysis of small sample microarray data. BMC Bioinformatics 6: 187.
27. Antonov, A. V., T. Schmidt, Y. Wang, and H. W. Mewes. 2008. ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data. Nucleic Acids Res. 36: W347-W351.
28. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102: 15545-15550.
29. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl 1):S9-S17.
30. Varin, A., S. Mukhopadhyay, G. Herbein, and S. Gordon. 2009. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood. 115: 353-362.
31. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453-461.
32. Sachais, B. S., A. Kuo, T. Nassar, J. Morgan, K. Kariko, K. J. Williams, M. Feldman, M. Aviram, N. Shah, L. Jarett, et al. 2002. Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Blood 99: 3613-3622.
33. Newby, A. C. 2008. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 28: 2108-2114.
34. Bengtsson, E., J. Nilsson, and S. Jovinge. 2008. Cystatin C and cathepsins in cardiovascular disease. Front. Biosci. 13: 5780-5786.
35. Koenen, R. R., P. von Hundelshausen, I. V. Nesmelova, A. Zernecke, E. A. Liehn, A. Sarabi, B. K. Kramp, A. M. Piccinini, S. R. Paludan, M. A. Kowalska, et al. 2009. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15: 97-103.